Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 1:10 AM
Ignite Modification Date:
2025-12-25 @ 1:10 AM
NCT ID:
NCT06681493
Brief Summary:
Part A
Primary objective:
• To evaluate the safety, tolerability, and pharmacokinetic profile of a single dose of YZJ-4729 tartrate injection.
Secondary objectives:
* To investigate the PK/PD profile of YZJ-4729 tartrate injection administered as a single dose;
* To investigate the metabolic transformation characteristics of YZJ-4729 tartrate;
* To assess the relationship between plasma concentrations and change in QT interval (C-QT) and the effect on QT interval in subjects after a single dose of YZJ-4729 tartrate injection.
Part B
Primary objective:
• To evaluate the safety, tolerability and pharmacokinetic profile of YZJ-4729 tartrate injection administered at the same dose and at different infusion rates .
Secondary objectives:
• To investigate the PK/PD profile of YZJ-4729 tartrate injection administered at the same dose and at different infusion rates.
Study:
NCT06681493
Study Brief:
Protocol Section:
NCT06681493